Presented at the American Laryngological Association meeting, Orlando, FL, U.S.A., May 1–2, 2008.
Revision Laryngeal Surgery for the Suboptimal Injection of Calcium Hydroxylapatite†
Version of Record online: 2 JAN 2009
Copyright © 2008 The Triological Society
Volume 118, Issue 12, pages 2260–2263, December 2008
How to Cite
Chheda, N. N., Rosen, C. A., Belafsky, P. C., Simpson, C. B. and Postma, G. N. (2008), Revision Laryngeal Surgery for the Suboptimal Injection of Calcium Hydroxylapatite. The Laryngoscope, 118: 2260–2263. doi: 10.1097/MLG.0b013e318184e6ee
Supported by Bioform (to C.A.R.).
Drs. Rosen, Simpson, and Postma are on the Speaker's Bureau for Bioform.
- Issue online: 2 JAN 2009
- Version of Record online: 2 JAN 2009
- Manuscript Accepted: 27 JUN 2008
- Vocal fold augmentation;
- injection laryngoplasty;
- calcium hydroxylapatite;
- superficial injection
Objective: The objective of this study was to describe the management of suboptimal injection of calcium hydroxylapatite during augmentation laryngoplasty.
Study Design: A retrospective review was conducted at four Voice and Swallowing centers to identify patients who had a suboptimal injection of calcium hydroxylapatite during augmentation laryngoplasty.
Results: Five patients (ages 19–75) were identified with an impaired voice secondary to a superficial injection of calcium hydroxylapatite or over-medialization of the true vocal fold. All patients underwent revision surgery with all experiencing subjective and objective improvement.
Conclusion: Microflap excision can lead to successful return of vibratory function after a suboptimal injection of calcium hydroxylapatite. Complete control of the initial injection is paramount to avoiding this complication.